Vitaros alprostadil regulatory update

Apricus said Vitaros alprostadil was approved to treat erectile dysfunction (ED) in Austria, Cyprus, the Czech Republic, Denmark, Finland, Greece, Iceland, Norway, Poland, Portugal, Romania and the Slovak Republic. In June 2013, Vitaros was approved for ED under Europe’s decentralized procedure, with the Netherlands acting as the reference member state, in Luxembourg, Belgium, France, Germany, Ireland, Italy, the Netherlands, Spain, Sweden and the U.K. The product is a topical prostaglandin E1 (PGE1) cream formulated with Apricus’ NexACT transdermal delivery technology. ...